Rifampin

Product NDC: 61748-018
11-digit product format: 617480018
Labeler code: 61748
Product ID: 61748-018_eb950d35-ef45-4f4b-a183-982d7c4d48a7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Rifampin
Dosage form: CAPSULE
Route: ORAL
Labeler: Akorn
Application: ANDA065028
Marketing category: ANDA
Marketing start: 2001-07-01
Marketing end: 0000-00-00
Substance: RIFAMPIN
Active strength: 300 mg/1
Pharmacologic classes: Rifamycin Antibacterial [EPC], Rifamycins [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	61748-018		D	Discontinued by firm	2026-08-17
excluded package	package	61748-018	61748-018-01	D	Discontinued by firm	2026-08-17
excluded package	package	61748-018	61748-018-11	D	Discontinued by firm	2026-08-17
excluded package	package	61748-018	61748-018-30	D	Discontinued by firm	2026-08-17
excluded package	package	61748-018	61748-018-60	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 75 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61748-018-60	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61748-018-30	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61748-018-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61748-018-11	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61748-018-60	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61748-018-11	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61748-018-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61748-018-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61748-018-60	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61748-018-11	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61748-018-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61748-018-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61748-018-60	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61748-018-11	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61748-018-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61748-018-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61748-018-60	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61748-018-11	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61748-018-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61748-018-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61748-018-60	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61748-018-11	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61748-018-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61748-018-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61748-018-60	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61748-018-11	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61748-018-01	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61748-018-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61748-018-60	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61748-018-11	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61748-018-01	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61748-018-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61748-018-60	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61748-018-11	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61748-018-01	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61748-018-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61748-018-60	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61748-018-11	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61748-018-01	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61748-018-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61748-018-60	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61748-018-11	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61748-018-01	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61748-018-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61748-018-60	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61748-018-11	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61748-018-01	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61748-018-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065028-001	RIFAMPIN	RIFAMPIN	150MG	CAPSULE / ORAL			2001-03-14
A065028-002	RIFAMPIN	RIFAMPIN	300MG	CAPSULE / ORAL			2001-03-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL		2001-03-14	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL		2001-03-14	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL	AB	2001-03-14	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL	AB	2001-03-14	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL	AB	2001-03-14	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL	AB	2001-03-14	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL	AB	2001-03-14	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL	AB	2001-03-14	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL	AB	2001-03-14	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL	AB	2001-03-14	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065028-001	RIFAMPIN	150MG	CAPSULE / ORAL	AB	2001-03-14	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065028-002	RIFAMPIN	300MG	CAPSULE / ORAL	AB	2001-03-14	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 52 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065028-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065028-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065028-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065028-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065028-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065028-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065028-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065028-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065028-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065028-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065028-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065028-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065028-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065028-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065028-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A065028-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065028-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A065028-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065028-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A065028-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065028-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A065028-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065028-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A065028-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065028-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A065028-002	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065028-001	AB	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065028-002	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065028-001	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A065028-002	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065028-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A065028-002	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065028-001	AB	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065028-002	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065028-001	AB	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065028-002	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065028-001	AB	1	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065028-002	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065028-001	AB	1	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065028-002	AB	1	`3f0d92c62455…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
29eec95f-f163-42e8-88a8-3cb43899b2b7	Product name	3	20160405
26abd97e-907b-0cb8-84ee-99fb15297ada	Product name	1	20140508
7cf7f62d-3767-728f-c117-96e96c1ed8bf	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
61748-018-01	2025-09-12	RIFAMPIN CAPSULES, USP
61748-018-11	2025-09-12	RIFAMPIN CAPSULES, USP
61748-018-30	2025-09-12	RIFAMPIN CAPSULES, USP
61748-018-60	2025-09-12	RIFAMPIN CAPSULES, USP
61748-018-01	2024-01-30	RIFAMPIN CAPSULES, USP
61748-018-11	2024-01-30	RIFAMPIN CAPSULES, USP
61748-018-30	2024-01-30	RIFAMPIN CAPSULES, USP
61748-018-60	2024-01-30	RIFAMPIN CAPSULES, USP

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61748-018-01	EA - Each	61748-018	cabe8879-70c0-480a-9324-0124b4eab092	1	2012-07-24
61748-018-11	EA - Each	61748-018	e63fd158-161b-4360-877c-a6d0c80e4d86	1	2012-07-24
61748-018-30	EA - Each	61748-018	ae9ca5c2-e0d6-4512-8770-711c9926fe9b	1	2012-07-24
61748-018-60	EA - Each	61748-018	97759919-6dd8-48a7-9631-42c057532f3c	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
RIFAMPIN	ACTIVE INGREDIENT	VJT6J7R4TR	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
RIFAMPIN	ACTIVE MOIETY	VJT6J7R4TR	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
BUTYL ALCOHOL	INACTIVE INGREDIENT	8PJ61P6TS3	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
GELATIN	INACTIVE INGREDIENT	2G86QN327L	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
SHELLAC	INACTIVE INGREDIENT	46N107B71O	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	RIFAMPIN CAPSULE [VERSAPHARM INCORPORATED]	4
RIFAMPIN	ACTIVE INGREDIENT	VJT6J7R4TR	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
RIFAMPIN	ACTIVE INGREDIENT	VJT6J7R4TR	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
RIFAMPIN	ACTIVE MOIETY	VJT6J7R4TR	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
RIFAMPIN	ACTIVE MOIETY	VJT6J7R4TR	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
BUTYL ALCOHOL	INACTIVE INGREDIENT	8PJ61P6TS3	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
BUTYL ALCOHOL	INACTIVE INGREDIENT	8PJ61P6TS3	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	RIFAMPIN CAPSULE, COATED [H.J. HARKINS COMPANY, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	RIFAMPIN CAPSULE, COATED [CARILION MATERIALS MANAGEMENT]	2
RIFAMPIN	ACTIVE INGREDIENT	VJT6J7R4TR	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
RIFAMPIN	ACTIVE MOIETY	VJT6J7R4TR	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
BUTYL ALCOHOL	INACTIVE INGREDIENT	8PJ61P6TS3	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
DIMETHICONE 410	INACTIVE INGREDIENT	TYU5GP6XGE	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	RIFAMPIN CAPSULE, COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61748-018	RIFAMPIN CAPSULE [AKORN]	7	Legacy NDC	20220714_26a2dbca-5090-4f6c-99ed-e11a70bb5af0.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
VJT6J7R4TR	RIFAMPIN	13292-46-1	RIFAMPIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198202	rifAMPin 300 MG Oral Capsule	PSN	3e7324bb-9965-49c7-8e22-557e5b67a588	9
198202	rifampin 300 MG Oral Capsule	SCD	3e7324bb-9965-49c7-8e22-557e5b67a588	9
198202	rifAMPin 300 MG Oral Capsule	PSN	3cc0bcd2-37d7-4a7b-808b-980d864281af	2
198202	rifAMPin 300 MG Oral Capsule	PSN	4ca272ce-2781-4ead-82d2-e7c404533a41	2
198202	rifAMPin 300 MG Oral Capsule	PSN	dc86fc3f-8903-40ee-ad74-099739bc024c	2
198202	rifampin 300 MG Oral Capsule	SCD	3cc0bcd2-37d7-4a7b-808b-980d864281af	2
198202	rifampin 300 MG Oral Capsule	SCD	4ca272ce-2781-4ead-82d2-e7c404533a41	2
198202	rifampin 300 MG Oral Capsule	SCD	dc86fc3f-8903-40ee-ad74-099739bc024c	2
198202	rifAMPin 300 MG Oral Capsule	PSN	eef30745-075c-4430-8271-2c3f353f40a2	1
198202	rifampin 300 MG Oral Capsule	SCD	eef30745-075c-4430-8271-2c3f353f40a2	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
61748-018-01	61748001801	100 CAPSULE in 1 BOTTLE, PLASTIC (61748-018-01)	100 capsule	2001-07-01	0000-00-00	No	No	Current
61748-018-11	61748001811	10 BLISTER PACK in 1 CARTON (61748-018-11) > 10 CAPSULE in 1 BLISTER PACK	10 blister pack	2001-07-01	0000-00-00	No	No	Current
61748-018-30	61748001830	30 CAPSULE in 1 BOTTLE, PLASTIC (61748-018-30)	30 capsule	2001-07-01	0000-00-00	No	No	Current
61748-018-60	61748001860	60 CAPSULE in 1 BOTTLE, PLASTIC (61748-018-60)	60 capsule	2001-07-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
RIFAMPIN CAPSULES, USP	Golden State Medical Supply, Inc.	2023-08-14	HUMAN PRESCRIPTION DRUG LABEL	5
RIFAMPIN CAPSULES, USP	Akorn \| Patheon Pharmaceuticals Inc.	2022-07-12	HUMAN PRESCRIPTION DRUG LABEL	7
RIFAMPIN CAPSULES, USP	A-S Medication Solutions	2021-08-24	HUMAN PRESCRIPTION DRUG LABEL	9
RIFAMPIN CAPSULES, USP	REMEDYREPACK INC.	2020-02-19	HUMAN PRESCRIPTION DRUG LABEL	5
RIFAMPIN CAPSULES, USP	Central Texas Community Health Centers	2016-12-09	HUMAN PRESCRIPTION DRUG LABEL	2
RIFAMPIN CAPSULES, USP	H.J. Harkins Company, Inc.	2012-01-19	HUMAN PRESCRIPTION DRUG LABEL	2
RIFAMPIN CAPSULES, USP	Carilion Materials Management	2011-08-04	HUMAN PRESCRIPTION DRUG LABEL	2
Rifampin Capsules, USP	State of Florida DOH Central Pharmacy	2010-06-01	HUMAN PRESCRIPTION DRUG LABEL	1